Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? (Q90646184)

PubMed ID

32211771

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

title

Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? (English)

1 reference

PubMed ID

32211771

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

1 reference

1 reference

1 reference

1 reference

Maurizio Guastalegname

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Alfredo Vallone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

24 March 2020

1 reference

PubMed ID

32211771

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

15 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness

27 May 2020

cites work

1 reference

12 December 2020

Effects of chloroquine on viral infections: an old drug against today's diseases?

1 reference

12 December 2020

Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice

1 reference

12 December 2020

Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression

1 reference

12 December 2020

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

1 reference

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

12 December 2020

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

1 reference

12 December 2020

[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]

1 reference

12 December 2020

Of chloroquine and COVID-19

1 reference

12 December 2020

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIAA321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-15220

0 references

1125825564

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32211771%20AND%20SRC:MED&resulttype=core&format=json